Soleus Capital Management’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-50,000
Closed -$1.91M – 104
2025
Q2
$1.91M Buy
+50,000
New +$1.41M 0.13% 77
2024
Q3
– Sell
-80,236
Closed -$3.08M – 105
2024
Q2
$3.08M Buy
80,236
+71,736
+844% +$4.04M 0.27% 71
2024
Q1
$755K Buy
8,500
+750
+10% +$48.7K 0.06% 85
2023
Q4
$482K Sell
7,750
-132,586
-94% -$9.95M 0.05% 67
2023
Q3
$16.9M Buy
140,336
+16,247
+13% +$2.28M 1.56% 21
2023
Q2
$20.8M Buy
124,089
+69,591
+128% +$14.5M 2.31% 13
2023
Q1
$13.8M Sell
54,498
-14,320
-21% -$3.31M 1.43% 21
2022
Q4
$12.5M Sell
68,818
-64,476
-48% -$13.9M 1.8% 21
2022
Q3
$31.4M Sell
133,294
-30,508
-19% -$7.71M 4.27% 4
2022
Q2
$42.1M Buy
163,802
+152,421
+1,339% +$40.8M 6.57% 2
2022
Q1
$3.84M Buy
+11,381
New +$3.76M 0.5% 44
2021
Q4
– Sell
-10,100
Closed -$5.25M – 86
2021
Q3
$5.25M Sell
10,100
-36,616
-78% -$16.1M 0.82% 34
2021
Q2
$15.7M Buy
46,716
+680
+1% +$186K 2.41% 12
2021
Q1
$9.94M Buy
46,036
+25,208
+121% +$5.54M 1.79% 11
2020
Q4
$4.71M Buy
+20,828
New +$4.48M 0.62% 21

Other funds holding SKIN

Soleus Capital Management's SKIN Position: Q3 2025 in Review

Soleus Capital Management sold out of SkinHealth Systems (SKIN) in Q3 2025, closing a stake of 50,000 shares — an estimated $1.91M sold.

Soleus Capital Management first reported a position in SKIN in Q4 2020 and held it in 15 quarters. The position peaked at $42.1M in Q2 2022. 110 funds tracked by Wall St. Rank hold SKIN as of Q3 2025.

  • Soleus Capital Management reported no remaining SkinHealth Systems position as of Q3 2025 after selling out during the quarter.
  • Soleus Capital Management sold 50,000 SkinHealth Systems shares in Q3 2025, an estimated $1.91M.
  • Soleus Capital Management first reported a position in SkinHealth Systems in Q4 2020 and held it in 15 quarters.
  • Soleus Capital Management's SkinHealth Systems position peaked at $42.1M in Q2 2022.
  • 110 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2025.

Based on Soleus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.